A2A Adenosine Receptor Agonist for the Treatment of IBD

Award Information
Agency: Department of Health and Human Services
Branch: N/A
Contract: 1R43DK066880-01
Agency Tracking Number: DK066880
Amount: $673,023.00
Phase: Phase I
Program: SBIR
Awards Year: 2004
Solitcitation Year: 2004
Solitcitation Topic Code: N/A
Solitcitation Number: PHS2004-2
Small Business Information
ADENOSINE THERAPEUTICS, LLC
310 FOURTH STREET NE, SUITE 201, CHARLOTTESVILLE, VA, 22902
Duns: N/A
Hubzone Owned: N
Woman Owned: N
Socially and Economically Disadvantaged: N
Principal Investigator
 ROBERT Thompson
 (434) 951-9484
 RDT@ADENRX.COM
Business Contact
 ROBERT CAPON
Phone: (434) 220-9400
Email: ROB@ADENRX.COM
Research Institution
N/A
Abstract
DESCRIPTION (provided by applicant): Adenosine Therapeutics, LLC (ATL) is a biotechnology company started in Charlottesville, Virginia in 1999. ATL owns patents on the formulation and use of a family of potent and highly selective agonists of A2A adenosin

* information listed above is at the time of submission.

Agency Micro-sites

US Flag An Official Website of the United States Government